Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Patients With Rheumatoid Arthritis Continue to Benefit After Halting TNF-alpha Inhibitor Therapy
Link ID 838
Title Patients With Rheumatoid Arthritis Continue to Benefit After Halting TNF-alpha Inhibitor Therapy
Url http://www.medscape.com/viewarticle/565701?src=rss
Description The improvement gained through tumor necrosis factor-alpha inhibitor therapy persists after withdrawal of treatment. Medscape Medical News
Category Articles > Rheumatology
Keywords
Date Nov 15, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Etanercept Linked to Increased Uveitis Risk
  Uveitis occurs more commonly in association with etanercept than with other tumor necrosis factor (TNF) inhibitors, according to a new report. Reuters Health Information
Category:   Articles > Rheumatology


2. Anti-TNF Therapy Ups Antioxidant Effect of HDL Cholesterol
  In a small study of rheumatoid arthritis patients, treatment with the anti-tumor necrosis factor (anti-TNF) agent infliximab appeared to increase the antioxidative capacity of HDL cholesterol. Reuters Health Information
Category:   Articles > Rheumatology


3. TNF Antagonists Not Linked to Major Malignant Lymphoma Risk in RA Patients
  Anti-tumor necrosis factor (TNF) therapy does not markedly increase the risk of malignant lymphoma in patients with rheumatoid arthritis, according to the results of a Swedish study. This study is one of the largest to-date to assess effects of anti-TNF therapy in rheumatoid arthritis patients. Reuters Health Information
Category:   Articles > Rheumatology


4. Fibromyalgia Diagnosis Often Delayed
  Patients with symptoms suggestive of fibromyalgia generally wait from 5 months to 1.5 years (depending on the country) to make an appointment with their physician, according to the results of a survey released here to coincide with the European Union League Against Rheumatism Congress (EULAR) 2008. Reuters Health Information
Category:   Articles > Rheumatology


5. Diffuse Large B Cell Lymphoma Most Common Subtype in Patients With Lupus
  The most common subtype of lymphoma in systemic lupus erythematosus (SLE) patients is diffuse large B cell lymphoma (DLBCL), suggest results of a study published in the December issue of the Annals of Rheumatic Diseases. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS